Asia-Pacific
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
Nucleate Taiwan Unites Academia and Industry to Explore Healthcare Innovations Through AI
2024-10-22
JPMA on Japan’s Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List
2024-10-17
Illumina and NTU Hospital Sign Collaboration Agreement to Launch Large-Scale Whole Genome Sequencing Project
2024-10-16
BioJapan Winning with Tech Advancements, Collaborations, and Diverse Medical Strengths: Taiwan’s Delegation Brings Its Best to the Fore
2024-10-10
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
Thai Biotech Industry’s Promising Potential: Taiwan Works Toward Strengthening APAC Ties at Bio Asia Pacific—Collaboration is Key
2024-09-24
Core8 Australia, Truongson, and Him Lam Form VIEH Singapore to Drive Investment in Vietnam’s Duc Hoa 3 Industrial Park
2024-09-02
Taiwan’s Biotech Industry Directives: Six Strategic Aspects of AI Empowerment, Smart Healthcare, and Global Expansion
2024-08-29
Experts Advocate for Increased Incentives and Cost Reduction for Biosimilar Prescriptions at Asian Biotechnology Exhibition
2024-08-05
LATEST
Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
2024-11-08
Antibody-Drug Conjugates: Connecting Drugs to Cancer Cells and Unlocking Billions in Market Opportunities
2024-11-06